Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of...
58 KB (5,345 words) - 02:17, 27 August 2024
of t-FL (e.g. the addition to standard chemotherapy of agents such as rituximab) have improved overall survival times. These newer regimens may also delay...
67 KB (7,967 words) - 20:38, 20 July 2024
antibodies such as rituximab, which are increasingly being used as first-line treatment. In summer 2018, the FDA granted full approval to rituximab for this application...
17 KB (1,943 words) - 07:31, 29 July 2024
Additionally, ibrutinib down-modulates the expression of CD20 (target of rituximab/ofatumumab) by targeting the CXCR4/SDF1 axis. Together, these data are...
29 KB (2,605 words) - 21:22, 16 August 2024
90% to less than 20%. Immunosuppressants, such as glucocorticoids, and rituximab may also be used. Platelet transfusions are generally not recommended...
48 KB (5,009 words) - 23:59, 7 August 2024
patients who cannot use corticosteroids. The anti-CD20 monoclonal antibody rituximab has been found to be effective in treating some otherwise refractory cases...
13 KB (1,321 words) - 02:43, 17 August 2024
bendamustine with rituximab. Second line treatment may include fludarabine, combined with cyclophosphamide and/or mitoxantrone, usually with rituximab. Cladribine...
41 KB (4,549 words) - 08:59, 25 January 2024
multicenter, open-label trial of venetoclax with rituximab (VEN+R) versus bendamustine with rituximab (B+R) in 389 participants with CLL who had received...
27 KB (2,564 words) - 02:20, 16 July 2024
methotrexate for moderate to severe rheumatoid arthritis. The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid...
15 KB (1,475 words) - 17:04, 29 July 2024
promise in this technique treating anti-MAG neuropathies.[citation needed] Rituximab is considered to be one of the most promising drugs in the treatment of...
17 KB (2,039 words) - 18:54, 12 November 2023
them were HIV positive. This is a large improvement over administering rituximab. [citation needed] The monoclonal antibody against the CD20 protein has...
35 KB (4,016 words) - 11:33, 15 August 2024
corticosteroids. Sometimes the chimeric anti-CD20 monoclonal antibody, rituximab, is added to this treatment regimen to form the R-CHOP regimen. R-miniCHOP...
12 KB (1,017 words) - 19:41, 26 July 2024
follicular lymphoma as a second line treatment to a regimen containing rituximab. It was not tested in pregnant women. Obinutuzumab has two black box warnings:...
18 KB (1,533 words) - 13:11, 6 August 2024
disseminated disease at presentation or lack of response to local treatment. Rituximab, the anti-CD20 chimeric antibody, is a key component of therapy. Responses...
19 KB (2,138 words) - 02:22, 25 July 2024
Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It was approved by the US Food and Drug Administration (FDA) in...
18 KB (1,746 words) - 01:31, 27 August 2024
combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE. [R]-ICE regimen consists of:[citation needed] Rituximab - an anti-CD20 monoclonal...
3 KB (183 words) - 17:16, 14 May 2024
Cancer immunotherapy (section Rituximab)
destruction by the immune system. Examples of such antibodies include rituximab (targeting CD-20), trastuzumab (targeting HER-2), and cetuximab (targeting...
89 KB (10,338 words) - 14:21, 16 July 2024
(MCL), with or without prior rituximab-containing chemoimmunotherapy treatment, is bendamustine with mitoxantrone and rituximab. In Germany in 2012 it has...
14 KB (1,211 words) - 03:25, 25 July 2024
often treated differently from classic Hodgkin lymphoma, including using rituximab in combination with AVBD chemotherapy, though individual cases vary and...
87 KB (8,529 words) - 19:54, 23 August 2024
Mayerhoefer ME, Lukas J, Zielinski CC, Müllauer L, Raderer M (2014). "Rituximab plus bendamustine is active in pretreated patients with extragastric marginal...
23 KB (634 words) - 23:47, 16 August 2024
common upon discontinuation of rituximab, but the medication can be restarted to achieve subsequent remission. Rituximab can be combined with bendamustine...
26 KB (3,084 words) - 06:51, 20 July 2024
follitropin alfa, infliximab, insulin aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab. A research article about "Maximizing the...
95 KB (6,480 words) - 22:51, 13 May 2024
as rituximab or cyclophosphamide and high-dose corticosteroids to control the symptoms of the disease and azathioprine, methotrexate, or rituximab to...
30 KB (3,155 words) - 14:11, 9 July 2024
corticosteroid and immunomodulator treatments are not sufficient, rituximab may also be used. Rituximab has been shown to induce and maintain remission. AIP does...
21 KB (2,306 words) - 18:19, 5 July 2024
Management of ME/CFS (section Rituximab)
CoQ10. A potential use for rituximab was identified by two Norwegian doctors who were treating people who had cancer with rituximab; two people also had chronic...
53 KB (5,871 words) - 15:08, 15 June 2024
Other common treatments include baclofen, intravenous immunoglobin, and rituximab. Limited but encouraging therapeutic experience of haematopoietic stem...
26 KB (2,881 words) - 16:06, 26 August 2024
anti-CD20 monoclonal antibody rituximab (Rituxan, Mabthera) it is called R-DHAP or DHAP-R. [R]-DHAP regimen consists of: Rituximab, a monoclonal antibody, directed...
2 KB (125 words) - 11:31, 25 July 2024
folic acid. Rituximab combined with methotrexate appears to be more effective in improving symptoms compared to methotrexate alone. Rituximab works by decreasing...
147 KB (16,022 words) - 14:49, 13 August 2024
monoclonal antibodies, are also used in these conditions and include rituximab, basiliximab and eculizumab. Blood products including intravenous immunoglobulin...
25 KB (2,838 words) - 05:46, 13 August 2024
such as Rituximab, an anti-CD20 antibody, which was found to improve otherwise severe cases of recalcitrant pemphigus vulgaris. Currently rituximab is considered...
19 KB (1,951 words) - 13:36, 28 May 2024